CN111172102A - Method for culturing adventitia cells of blood vessels of mammals - Google Patents
Method for culturing adventitia cells of blood vessels of mammals Download PDFInfo
- Publication number
- CN111172102A CN111172102A CN202010213089.5A CN202010213089A CN111172102A CN 111172102 A CN111172102 A CN 111172102A CN 202010213089 A CN202010213089 A CN 202010213089A CN 111172102 A CN111172102 A CN 111172102A
- Authority
- CN
- China
- Prior art keywords
- adventitia
- tissue
- fibroblasts
- cells
- blood vessel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002808 connective tissue Anatomy 0.000 title claims abstract description 140
- 238000000034 method Methods 0.000 title claims abstract description 91
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 46
- 238000012258 culturing Methods 0.000 title claims abstract description 25
- 241000124008 Mammalia Species 0.000 title claims abstract description 21
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 85
- 210000004027 cell Anatomy 0.000 claims abstract description 73
- 210000001519 tissue Anatomy 0.000 claims abstract description 61
- 230000002792 vascular Effects 0.000 claims abstract description 25
- 230000008569 process Effects 0.000 claims description 9
- 210000002945 adventitial reticular cell Anatomy 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 abstract description 15
- 230000008901 benefit Effects 0.000 abstract description 7
- 230000010261 cell growth Effects 0.000 abstract description 6
- 238000000338 in vitro Methods 0.000 abstract description 5
- 102000004190 Enzymes Human genes 0.000 abstract description 4
- 108090000790 Enzymes Proteins 0.000 abstract description 4
- 230000004962 physiological condition Effects 0.000 abstract description 4
- 230000006978 adaptation Effects 0.000 abstract description 2
- 238000012423 maintenance Methods 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 11
- 241000700159 Rattus Species 0.000 description 10
- 238000011160 research Methods 0.000 description 9
- 108010019160 Pancreatin Proteins 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000010166 immunofluorescence Methods 0.000 description 6
- 229940055695 pancreatin Drugs 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 102000013127 Vimentin Human genes 0.000 description 5
- 108010065472 Vimentin Proteins 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 239000008055 phosphate buffer solution Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 210000000709 aorta Anatomy 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000012136 culture method Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 239000012894 fetal calf serum Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 238000011532 immunohistochemical staining Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 210000000115 thoracic cavity Anatomy 0.000 description 4
- 230000003187 abdominal effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000005048 vimentin Anatomy 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- 208000032594 Vascular Remodeling Diseases 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000002266 amputation Methods 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003125 immunofluorescent labeling Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229960002275 pentobarbital sodium Drugs 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 206010003162 Arterial injury Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 238000000116 DAPI staining Methods 0.000 description 1
- 208000002251 Dissecting Aneurysm Diseases 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000004888 thoracic abdominal cavity Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
The invention discloses a method for culturing adventitia cells of a mammal blood vessel, which relates to the technical field of cell culture and comprises the following steps: obtaining a tubular vascular adventitia by an oversleeve method; cutting the adventitia into blocks to obtain a plurality of adventitia tissue blocks, wherein the adventitia tissue blocks contain fibroblasts; performing primary culture on fibroblasts in the adventitia tissue block by a tissue adherence method to obtain generated fibroblasts. The method for obtaining the adventitia of the blood vessel by the oversleeve method has the advantages of simple steps, short time, reduction of pollution of fibroblast in the adventitia of the blood vessel, maintenance of the original tissue structure to a great extent by adopting the tissue adherence method for primary culture, closer cell growth under physiological conditions due to no enzyme treatment, and contribution to adaptation of the method to in vitro culture environment.
Description
Technical Field
The invention relates to the technical field of cell culture, in particular to a method for culturing adventitia cells of blood vessels of mammals.
Background
At present, the adventitia plays an important role in the occurrence and development processes of vascular remodeling, is the structural basis of the incidence of various cardiovascular diseases, and the research aiming at the adventitia is one of the current cardiovascular field research hotspots. Fibroblasts (AFs) are the major component of the adventitia of blood vessels, and Siow et al used an adenovirus vector expressing B2 galactosidase (Lac 2 z) to label fibroblasts on a rat carotid artery endothelial pull model, and found that the fibroblasts migrated from the adventitia to the intima after arterial injury, which directly proved that the fibroblasts participated in the development and progression of atherosclerosis. Under the action of in vivo vasoactive substances, the collagen participates in the processes of cell phenotype transformation, proliferation, apoptosis, migration and collagen synthesis and secretion by secreting active factors, thereby participating in the processes of vascular function regulation and repair. Fibroblasts (AFs) have become a new target for the treatment of cardiovascular diseases.
Therefore, establishing a simple, efficient and feasible primary fibroblast (AFs) isolation culture method is an essential link for researching the biological characteristics of As under the stimulation action of various factors, selecting a proper method to rapidly generate fibroblast (AFs) is of great significance for developing the research field of vascular remodeling, and a tissue adherence method is commonly used As A Fibroblast (AFs) culture method, but the report of isolating rat primary aorta by the cuff method is rare.
On the other hand, in the prior art, the cost of the traditional primary culture is high, and the period is long, so that the cell culture is usually continued by subculture, but the subcultured cells have certain defects in the cell research process.
Disclosure of Invention
Accordingly, the present invention is directed to a method for culturing adventitia cells in a mammal, which solves at least some of the problems of the related art.
The present application provides a method for culturing adventitial cells in a mammalian blood vessel, comprising: obtaining a tubular vascular adventitia by an oversleeve method; cutting the vascular adventitia into blocks to obtain a plurality of vascular adventitia tissue blocks, wherein the vascular adventitia tissue blocks contain fibroblasts; and performing primary culture on the fibroblasts in the adventitia tissue block by a tissue adherence method to obtain generated fibroblasts.
In some embodiments, the obtaining a tubular adventitia by a cuff method comprises: placing the isolated blood vessel in a culture medium, fixing one end of the blood vessel, and stripping the blood vessel adventitia from the fixed end to the flat laying end to obtain the tubular blood vessel adventitia.
In some embodiments, the adventitia tissue mass has a volumetric range of between 2mm and 3mm castration.
In some embodiments, the primary culturing of fibroblasts in the adventitia tissue mass by tissue apposition comprises: flatly laying and attaching the adventitia tissue block to the wall of a container, and putting the container into an incubator for primary culture; repeating the following steps for a plurality of times on the adventitia tissue block to carry out primary culture: and when the fibroblasts generated on the vascular adventitia tissue block reach a preset density, stripping the generated fibroblasts from the vascular adventitia tissue block to obtain generated fibroblasts, and continuously performing primary culture on the stripped vascular adventitia tissue block by a tissue wall pasting method.
In some embodiments, the method for culturing adventitia cells in a mammal further comprises:
and in the process of repeatedly carrying out primary culture on the adventitia tissue block, when the adventitia tissue block falls off from the wall of the container, re-attaching the adventitia tissue block to the wall, and carrying out primary culture.
In some embodiments, the predetermined density ranges from 80% to 90%.
In some embodiments, the container is a 6-well plate.
In some embodiments, the attaching the adventitia tissue piece to the wall of the container in a flat state includes: at least two vascular adventitia tissue blocks are flatly attached to the well bottom in each well of the 6-well plate.
In some embodiments, the method for culturing adventitia cells in a mammal further comprises: and subculturing the generated fibroblasts.
The invention has the advantages that:
the method for culturing the mammal adventitia cells obtains the adventitia cells through the oversleeve method, has simple steps and short time, reduces the pollution of fibroblast in the adventitia, adopts the tissue adherence method to carry out primary culture, maintains the original tissue structure to a great extent, is more close to the cell growth under the physiological condition because of not being treated by enzyme, and is beneficial to adapting to the in vitro culture environment. In the two processes, the adventitia tissue block is subjected to primary culture in a short time, so that fibroblasts with similar genetic characters and fibroblast cells in the adventitia can be generated, and the method is suitable for cell morphology, function, differentiation and other researches.
In addition to the objects, features and advantages described above, other objects, features and advantages of the present invention are also provided. The present invention will be described in further detail below with reference to the drawings.
Drawings
The accompanying drawings, which are incorporated in and constitute a part of this application, illustrate embodiments of the invention and, together with the description, serve to explain the invention and not to limit the invention.
FIG. 1 is a schematic flow chart of a method for culturing adventitia cells in a mammal according to an embodiment of the present invention;
FIG. 2 is a schematic view under a microscope after 1 day of a mammalian adventitia cell culture method according to an embodiment of the present invention;
FIG. 3 is a schematic view under a microscope after 5 days of a mammalian adventitia cell culture method according to an embodiment of the present invention;
FIG. 4 is a schematic representation of primary cultured cells of fibroblasts prepared by the method of comparative example 1 under a microscope after 24 hours;
FIG. 5 is an immunofluorescence test chart of cells cultured by a mammalian adventitia cell culture method according to an embodiment of the present invention;
FIG. 6 is a schematic diagram showing immunohistochemical staining of cells cultured by a mammalian adventitia cell culture method according to an embodiment of the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is described in further detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Fig. 1 is a schematic flow chart of a mammalian adventitia cell culture method according to an embodiment of the present invention, and as shown in fig. 1, the present application provides a mammalian adventitia cell culture method, including the following steps:
step S101, obtaining tubular vascular adventitia through a sleeve method.
In the present embodiment, the isolated blood vessel refers to a blood vessel isolated from a mammal, such as rat, sheep, pig, etc. The sleeve method is used for extracting the adventitia of the blood vessel, the conventional blood vessel dissection is not needed for treatment, the operation is simple, the tissue is easier to adhere to the wall, the treatment time is short, and the pollution is reduced.
In some embodiments, step S101, obtaining the tubular adventitia by the cuff method, may be specifically implemented by:
step S101A, taking the culture of the adventitia cells of SD rat as an example, the method for culturing the adventitia cells of mammal blood vessels includes the following steps: SD rats were sacrificed by amputation after abdominal anesthesia with 2% pentobarbital sodium (35 mg/kg), immediately and completely soaked in 75% alcohol, and rapidly moved to a clean bench after 5 minutes. The thoracic cavity and abdominal cavity of the rat are cut along the median thoracic line, the abdominal viscera are gently turned to the left side, and the left lung lobes are turned.
Step S101B, the aorta is placed in a sterile culture dish and washed by phosphate buffer solution, one end of the blood vessel is fixed by holding the ophthalmology bending forceps with the left hand, and the adventitia of the blood vessel is peeled off by holding the other ophthalmology forceps with the right hand from top to bottom with slight force and is placed in a new culture dish (the intima and the media cells of the blood vessel are removed).
And S102, cutting the vascular adventitia into blocks to obtain a plurality of vascular adventitia tissue blocks, wherein the vascular adventitia tissue blocks contain fibroblasts.
In some embodiments, step S102, cutting the adventitia into pieces to obtain a plurality of adventitia tissue pieces, wherein the adventitia tissue pieces contain fibroblasts, specifically, the method can be implemented by:
step S102A, a small amount of culture fluid containing 30% (volume fraction) serum is added to the new petri dish, and the adventitia is cut into tissue blocks about 2-3mm high-speed cultivation.
In the embodiment of the application, the steps S101A to S102A can be completed within 10-20min, and the effect is better.
Step S103, performing primary culture on the fibroblasts in the adventitia tissue block by a tissue adherence method to obtain generated fibroblasts.
In the embodiment of the application, the tissue adherence method is a common, simple and easy primary culture method with high success rate, which is used for shearing a living tissue into small pieces after the living tissue is taken out and adhering the living tissue to the bottle wall to wait for the cells to be dissociated from the periphery of the tissue. The primary culture refers to the first culture which is carried out by taking out tissues or cells from the body, and is also called as the primary culture, the primary culture has short in vitro time, has similar genetic characters with the cells in the body, and is suitable for the research of cell morphology, function, differentiation and the like.
In some embodiments, step S103, performing primary culture on the fibroblasts in the adventitia tissue mass by tissue adherence to obtain generated fibroblasts, and specifically, may be implemented by the following steps:
step S103A, after the bottom surface of the 6-hole plate is infiltrated with fetal calf serum, serum is sucked away, and the tissue blocks in the culture dish are uniformly laid in the 6-hole plate, wherein each hole is provided with 5-6 tissue blocks.
And step S103B, adhering the tissue blocks of the step S103A to the wall, putting the tissue blocks into an incubator to adhere to the wall, taking out the 6-hole plate after 6-8h, and adding 300 mu L of culture solution containing 30% (volume fraction) of serum along the hole wall. Placing the mixture into an incubator and standing for 24 hours to generate fiber cells.
For the fibroblasts generated in the examples of the present application, the morphology and growth state of the cells were observed under an inverted microscope, fig. 2 is a schematic view of the method for culturing the mammalian adventitia cells under a microscope after 1 day, as shown in fig. 2, after primary culture 1-2d, the fibroblasts start to climb out from the periphery of the tissue mass, and the cells are in a fusiform or polygonal shape.
In the method for culturing the adventitia cells of the mammal blood vessels provided by the embodiment of the application, the tubular adventitia of the blood vessels is obtained by an oversleeve method; cutting the adventitia into blocks to obtain a plurality of adventitia tissue blocks, wherein the adventitia tissue blocks contain fibroblasts; performing primary culture on fibroblasts in the adventitia tissue block by a tissue adherence method to obtain generated fibroblasts. The method for obtaining the adventitia of the blood vessel by the oversleeve method has the advantages of simple steps, short time, reduction of pollution of fibroblast in the adventitia of the blood vessel, maintenance of the original tissue structure to a great extent by adopting the tissue adherence method for primary culture, closer cell growth under physiological conditions due to no enzyme treatment, and contribution to adaptation of the method to in vitro culture environment. In the two processes, the adventitia tissue block is subjected to primary culture in a short time, so that fibroblasts with similar genetic characters and fibroblast cells in the adventitia can be generated, and the method is suitable for cell morphology, function, differentiation and other researches.
In some embodiments, the obtaining a tubular adventitia by a cuff method comprises: placing the isolated blood vessel in a culture medium, fixing one end of the blood vessel, and stripping the blood vessel adventitia from the fixed end to the flat laying end to obtain the tubular blood vessel adventitia.
The blood vessel adventitia cell culture method of mammal that this application embodiment provided peels off the blood vessel adventitia from the stiff end of separation blood vessel to the tiling end slightly hard, and the blood vessel adventitia that acquires is cleaner, pollutes for a short time, does benefit to and cultivates the fibroblast in the blood vessel adventitia.
In some embodiments, the adventitia tissue mass has a volumetric range of between 2mm and 3mm castration.
The tissue block that 2 ~ 3mm volume were carried out to shearing the adventitia through of this application embodiment is favorable to the adherence operation for the adherence is tighter.
In some embodiments, the primary culturing of fibroblasts in the adventitia tissue mass by tissue apposition comprises: flatly laying and attaching the adventitia tissue block to the wall of a container, and putting the container into an incubator for primary culture; repeating the following steps for a plurality of times on the adventitia tissue block to carry out primary culture: and when the fibroblasts generated on the vascular adventitia tissue block reach a preset density, stripping the generated fibroblasts from the vascular adventitia tissue block to obtain generated fibroblasts, and continuously performing primary culture on the stripped vascular adventitia tissue block by a tissue wall pasting method.
In the embodiment of the present application, when fibroblasts generated on the adventitia tissue block reach a preset density, the generated fibroblasts are peeled off from the adventitia tissue block to obtain generated fibroblasts, and the peeled adventitia tissue block is subjected to primary culture by a tissue adherence method, which can be specifically realized by the following steps: when the concentration of the produced fibroblasts reaches a preset concentration, illustratively, when the concentration of the fibroblasts is as long as 80-90% of the confluent state, digestion is performed with pancreatin, wherein the amount of pancreatin is set as required, illustratively, the amount of pancreatin is 500. mu.L. After a large number of cells are exfoliated, carefully blowing the cells, particularly tissue edges, and showing that fibroblasts generated on the tissue edges are completely exfoliated under a microscope, adding 1ml of fetal calf serum culture solution with the volume fraction of 10% to terminate digestion, after passage, retaining tissue blocks, cleaning 6 pore plates by using 1ml of phosphate buffer solution, adding 2ml of fetal calf serum culture solution with the volume fraction of 30% along the pore walls, placing the pore plates into an incubator, continuously culturing the tissue blocks (if the tissue blocks are exfoliated, the tissues can be treated from a new adherent wall), and after 24 hours, the fibroblasts can be seen to be re-germinated from the tissue edges. The tissue can be used for more than 2 months, and the cell state is still good after 7 th digestion.
The application greatly shortens the cell culture time by repeatedly utilizing the digested tissue, and the cells cultured by the common method need to be transferred to the second generation for about 20 days and can only be utilized once, and need to be cultured again if continuing the test. The armhole method needs about 14 days for culturing the cells to be transferred to the second generation, the primary cells can be digested again every 3 to 5 days, and the adventitia tissue of the blood vessel can be used for at least 2 months. The morphology of primary cells generated from adventitia tissue was still good after 7 th extraction. Greatly reducing the culture time, saving the mouse treatment cost, being particularly suitable for extracting primary cells after model building, and being capable of extracting a large amount of cells in a short time after entering the culture of the primary cells of the carotid artery of the mouse.
The method for culturing the mammal adventitia cells, provided by the embodiment of the application, can generate fibroblasts with similar genetic characters to fibroblast cells in the adventitia by reserving the tissue blocks, re-attaching the tissue blocks to the wall and performing primary culture, is suitable for cell morphology, function, differentiation and other researches, can still generate the fibroblast cells in a short time according to the method, and has important significance in cell research.
In some embodiments, the method for culturing adventitia cells in a mammal further comprises:
and in the process of repeatedly carrying out primary culture on the adventitia tissue block, when the adventitia tissue block falls off from the wall of the container, re-attaching the adventitia tissue block to the wall, and carrying out primary culture.
In the embodiment of the application, when the adventitia tissue piece drops from the wall of the container, then it is right the adventitia tissue piece adheres to the wall again, every 2-3 days after adhering to the wall again the culture solution of interchangeable to guarantee that there is sufficient cell growth's culture solution (also can not change) in the container, through adhering to the wall repeatedly, can reach the rational utilization to the tissue piece, need not to acquire the tissue again, thereby reduce the experiment cost, shortened the experimental period.
In some embodiments, the predetermined density is in the range of 80% to 90%, and when the predetermined density of the cells reaches 80% to 90%, the generated fibroblasts are isolated to facilitate the growth of the cells. FIG. 3 is a schematic diagram of a mammalian adventitia cell culture method under a microscope after 5 days according to an embodiment of the present invention, and as shown in FIG. 3, the fibroblast density reaches 80-90% in a primary culture for 5 days.
In some embodiments, the container is a 6-well plate.
In the embodiment of the application, the container can be a culture vessel or a bottle, preferably, the application adopts a 6-well plate, and compared with the culture bottle, the 6-well plate is more beneficial to the operation of the experiment
In some embodiments, the pieces of adventitia tissue are attached flat to the wall of a container, comprising: and in each hole of the 6-hole plate, at least two vascular adventitia tissue blocks are tiled and attached to the hole wall.
In some embodiments, the method for culturing adventitia cells in a mammal further comprises: and subculturing the generated fibroblasts.
In the embodiment of the present application, when the concentration of the generated fibroblasts reaches a predetermined concentration, illustratively, when the concentration of the fibroblasts grows to 80-90% of the fused state, the digestion is performed with pancreatin, wherein the amount of pancreatin is set as required, illustratively, the amount of pancreatin is 500 μ L, after a large amount of cells are exfoliated, 1ml of culture solution containing 10% by volume of fetal calf serum is added to terminate the digestion, the culture solution is aspirated and centrifuged to obtain the generated fibroblasts, and the generated fibroblasts are subcultured.
According to the method for culturing the adventitia cells of the blood vessels of the mammals, the obtained fibroblasts grow dominantly through subculture and run in a radial or reticular interweaving manner, and the cells can be purified after twice passages. Fibroblasts can be generated in a short time by subculture, and the state, shape and similarity of the fibroblasts generated by the method are higher than the similarity of the fibroblasts in the adventitia tissue mass.
In some embodiments, the method for culturing adventitia cells in a mammal further comprises:
after the container is soaked by serum, the adventitia tissue blocks of the blood vessels are uniformly laid in the container and put into an incubator for adherence.
In the embodiment of the application, the tissue blocks are uniformly laid in a vessel soaked by serum, and the uniform laying is used for obtaining a better wall attaching effect; the container is soaked by serum and then is attached to the wall, on one hand, the container is prevented from being overdried, so that the activity and the attachment effect of tissue cells are influenced, on the other hand, the container can also provide nutritional factors for tissues, and can also prevent a tissue block from being soaked in a culture solution due to excessive culture solution; the attachment operation is performed by placing the cells in an incubator to keep the cells in a state simulating an in vivo environment, for example, the cell culture needs a certain gas environment, namely 95% of air (necessary for cell metabolism) and 5% of CO2, to maintain the pH value of the culture solution, and the temperature is set to 37 ℃ to effectively ensure that the cells are in an environment beneficial to growth and effective in maintaining cell activity.
In some embodiments, the tissue apposition methods mentioned herein may also be applied to endothelial cells and smooth muscle cells.
Comparative example 1
Obtaining the adventitia of the blood vessel by a common tissue adherence method: SD rats were sacrificed by amputation after abdominal anesthesia with 2% pentobarbital sodium (35 mg/kg), immediately and completely soaked in 75% alcohol, and rapidly moved to a clean bench after 5 minutes. The thoracic cavity and the abdominal cavity of a rat are cut along the median thoracic line, the abdominal cavity viscera are slightly turned to the left side, the lung lobe at the left side is turned, the aorta is taken to be arranged in a sterile PBS culture dish, the peripheral blood stain of the blood vessel is washed out, the aorta is transferred to a new sterile PBS culture dish to wash the residual blood inside and outside the blood vessel and then is transferred to another sterile PBS culture dish, the blood vessel is longitudinally split by an ophthalmic scissors, the inner membrane is faced upwards, the middle membrane smooth muscle layer close to the inner membrane is carefully torn down after the inner membrane is slightly scraped by an ophthalmic curved forceps from top to bottom, and the residual flocculent milky white tissue is the blood vessel adventitia.
The cell morphology and the growth state of the fibroblasts obtained by the method of comparative example 1 are observed under an inverted microscope, fig. 4 is a schematic diagram of the fibroblasts primarily cultured by the method of comparative example 1 under a microscope after 24 hours, and as shown in fig. 4, the fibroblasts of the adventitia of the blood vessel cultured by the method of comparative example 1 do not climb out in 24 hours and usually climb out after 72 hours.
The results show that:
the fibroblast generated by the culture method of the mammal adventitia cell provided by the embodiment of the application comprises the following steps: the adventitia tissue block is attached to the bottom of the culture bottle, fibroblasts start to climb out from the periphery of the tissue block after primary culture for 1-2 days, the cells are in spindle shapes and polygons (see figure 2), the cells grow for 1-2 days earlier compared with the common tissue wall pasting method (see figure 4) in comparative example 1, then the cells rapidly proliferate, the cells can grow to be in a fusion state after 5-6 days (see figure 3), and multiple layers are formed in the region close to the tissue block after 10-15 days.
Immunofluorescence assay
Vimentin is a characteristic protein of adventitia fibroblast and is used for identifying cells. The steps of immunofluorescence assay: taking cells in logarithmic phase, digesting, blowing and beating the cells into cell suspension, uniformly inoculating the cell suspension into a 96-well plate, taking out phosphate buffer solution for rinsing for 3 minutes multiplied by 3 times the next day; fixing 4% paraformaldehyde for 15 minutes at room temperature; rinsing with phosphate buffer solution for 3 min × 3 times; permeabilize 0.1% Triton X-100 in PBS for 20 minutes at room temperature, rinse with phosphate buffer solution for 3 minutes × 3 times; 5% BSA in PBS for 1 h; the supernatant was aspirated off, primary antibody was added: vimentin (1: 100), putting the wet box into a refrigerator at 4 ℃ overnight, the next day, rewarming at room temperature for 30 min, washing with PBS for 3 times, dripping FITC (1: 100) labeled secondary antibody into a dark room, and incubating at 37 ℃ for 1 h; PBS rinse, 3 min x3 times, care to keep out of light; DAPI staining nuclei, PBS rinsing, 3 minutes multiplied by 3 times, adding a proper amount of PBS, and observing the staining condition under an immunofluorescence microscope. And the smooth muscle cells were excluded by immunofluorescent staining of a-SMA in the same manner. The negative control primary antibody was replaced with PBS.
FIG. 5 is an immunofluorescence test chart of cells cultured by the mammalian adventitia cell culture method according to the embodiment of the present invention, and as shown in FIG. 5, the cells are positive and proved to be fibroblasts by detecting the same cells by both the ER-TR7 method and the vimentin method, and the cells generated in the embodiment of the present application have immunofluorescence and are proved to be fibroblasts, thereby excluding the possibility of smooth muscle cells.
FIG. 6 is a schematic diagram of immunohistochemical staining of cells cultured by a mammalian adventitial cell culture method according to an embodiment of the present invention, as shown in FIG. 6, wherein the cytoplasm of fibroblasts generated in the present application is stained brown-yellow (see the right side of FIG. 6), and the negative control is not stained, indicating that the cells are of mesenchymal origin.
In the application, we culture fibroblast (AFs) by using the oversleeve method, and the Vimentin protein performs immunofluorescence and immunohistochemical staining on purified fibroblast (AFs) respectively, and found that there are uniform Vimentin protein positive particles in the cytoplasm of fibroblast (AFs). Compared with the common tissue adherence method, the immunohistochemical staining judgment cuff method combining cell morphology and immunofluorescent agent is more suitable for primary culture of rat fibroblasts (AFs), the cultured cells are high in purity and good in growth state, and a sufficient and reliable target cell model is provided for researching the biological functions of the rat AFs. The original tissue structure is kept to a great extent by a tissue adherence method, and the cell growth is closer to the cell growth under the physiological condition because of no enzyme treatment, so that the method is beneficial to being adapted to the in vitro culture environment, and the defects of the enzyme digestion method can be avoided.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (9)
1. A method for culturing adventitia cells in a mammalian blood vessel, comprising:
obtaining a tubular vascular adventitia by an oversleeve method;
cutting the vascular adventitia into blocks to obtain a plurality of vascular adventitia tissue blocks, wherein the vascular adventitia tissue blocks contain fibroblasts;
and performing primary culture on the fibroblasts in the adventitia tissue block by a tissue adherence method to obtain generated fibroblasts.
2. The method of claim 1, wherein said obtaining of the tubular adventitia by the cuff method comprises:
placing the isolated blood vessel in a culture medium, fixing one end of the blood vessel, and stripping the blood vessel adventitia from the fixed end to the flat laying end to obtain the tubular blood vessel adventitia.
3. The method of claim 1, wherein the adventitia tissue mass is harvested from 2mm to 3mm by volume.
4. The method for culturing adventitial cells in a mammal according to claim 1, wherein the primary culture of fibroblasts in the adventitial tissue mass by tissue adherence comprises:
flatly laying and attaching the adventitia tissue block to the wall of a container, and putting the container into an incubator for primary culture;
repeating the following steps for a plurality of times on the adventitia tissue block to carry out primary culture:
and when the fibroblasts generated on the vascular adventitia tissue block reach a preset density, stripping the generated fibroblasts from the vascular adventitia tissue block to obtain generated fibroblasts, and continuously performing primary culture on the stripped vascular adventitia tissue block by a tissue wall pasting method.
5. The method of claim 4, further comprising:
and in the process of repeatedly carrying out primary culture on the adventitia tissue block, when the adventitia tissue block falls off from the wall of the container, re-attaching the adventitia tissue block to the wall, and carrying out primary culture.
6. The method of claim 4, wherein the predetermined density is in the range of 80% to 90%.
7. The method of claim 4, wherein the vessel is a 6-well plate.
8. The method of claim 7, wherein the step of laying the perivascular tissue mass on the wall of the container comprises:
at least two vascular adventitia tissue blocks are flatly attached to the well bottom in each well of the 6-well plate.
9. The method for culturing adventitia vasorum cell of a mammal according to any one of claims 1 to 8, further comprising:
and subculturing the generated fibroblasts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010213089.5A CN111172102B (en) | 2020-03-24 | 2020-03-24 | Method for culturing adventitia cells of mammal |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010213089.5A CN111172102B (en) | 2020-03-24 | 2020-03-24 | Method for culturing adventitia cells of mammal |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111172102A true CN111172102A (en) | 2020-05-19 |
CN111172102B CN111172102B (en) | 2024-08-27 |
Family
ID=70621931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010213089.5A Active CN111172102B (en) | 2020-03-24 | 2020-03-24 | Method for culturing adventitia cells of mammal |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111172102B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006204168A (en) * | 2005-01-27 | 2006-08-10 | Japan Tissue Engineering:Kk | Method of culturing |
CN106148272A (en) * | 2016-09-07 | 2016-11-23 | 山东大学 | The primary culture method of blood vessel adventitia fibroblast after a kind of transplanting |
CN109468271A (en) * | 2018-12-28 | 2019-03-15 | 广州暨大美塑生物科技有限公司 | A kind of skin histology source fibroblast quick separating cultural method |
CN110257322A (en) * | 2019-05-15 | 2019-09-20 | 重庆医科大学附属第一医院 | A kind of isolated culture method of primary thoracic aortic smooth muscle cell |
-
2020
- 2020-03-24 CN CN202010213089.5A patent/CN111172102B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006204168A (en) * | 2005-01-27 | 2006-08-10 | Japan Tissue Engineering:Kk | Method of culturing |
CN106148272A (en) * | 2016-09-07 | 2016-11-23 | 山东大学 | The primary culture method of blood vessel adventitia fibroblast after a kind of transplanting |
CN109468271A (en) * | 2018-12-28 | 2019-03-15 | 广州暨大美塑生物科技有限公司 | A kind of skin histology source fibroblast quick separating cultural method |
CN110257322A (en) * | 2019-05-15 | 2019-09-20 | 重庆医科大学附属第一医院 | A kind of isolated culture method of primary thoracic aortic smooth muscle cell |
Non-Patent Citations (3)
Title |
---|
宋方 等: "一套系统培养鼠主动脉血管壁细胞简单可靠的方法", 中国动脉硬化杂志, vol. 19, no. 4, 31 December 2011 (2011-12-31), pages 361 - 366 * |
马彦军 等: "大鼠胸主动脉外膜成纤维细胞的培养方法初探", 汕头大学医学院学报, vol. 24, no. 1, 31 December 2011 (2011-12-31), pages 51 - 52 * |
鹿燕敏;李兰芳;霍海如;谭余庆;: "大鼠血管外膜成纤维细胞的原代培养及生物学行为研究", 中国实验方剂学杂志, vol. 14, no. 10, 20 October 2008 (2008-10-20), pages 61 - 63 * |
Also Published As
Publication number | Publication date |
---|---|
CN111172102B (en) | 2024-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds | |
KR20070015519A (en) | Biological tissue sheet, method of forming the same and transplantation method by using the sheet | |
US7186558B2 (en) | Keratinocytes obtained from embryonic stem cells of mammals | |
CN105238738A (en) | Isolated culture method of piglet myocardial fibroblasts | |
Kasperczyk et al. | In vitro optimization of the Gallus domesticus oviduct epithelial cells culture | |
JP6626245B2 (en) | Compositions and methods for making reconstructed skin | |
Zhang et al. | Urothelial cell culture: stratified urothelial sheet and three-dimensional growth of urothelial structure | |
Vidyasekar et al. | A simplified protocol for the isolation and culture of cardiomyocytes and progenitor cells from neonatal mouse ventricles | |
CN113913375A (en) | Optimized culture medium, kit and culture method of human placenta-derived mesenchymal stem cells | |
CN106955372B (en) | Method for constructing tissue engineering corneal endothelium | |
CN113388576A (en) | Rat vascular smooth muscle cell culture medium and application thereof | |
CN111172102B (en) | Method for culturing adventitia cells of mammal | |
CN113061570B (en) | Method for culturing porcine hair papilla cells | |
Zhang et al. | Urothelial cell culture | |
JP5401669B2 (en) | Cardiomyocyte differentiation induction promotion method and differentiation induction method | |
CN112391337B (en) | Separation and primary culture method of pigeon crop fibroblasts | |
CN106591223A (en) | Separation and primary culture method for human skin fibroblasts | |
CN107841485B (en) | Culture method of myocardial ring | |
CN109771697B (en) | Dermal fibroblast skin sheet and construction method and application thereof | |
CN105624103A (en) | Improved separation preparation method for mouse thoracic aorta vascular smooth muscle cells | |
CN109810939B (en) | Culture method of pig peritoneal mesothelial cells | |
CN111925980A (en) | In-vitro culture method of chicken follicle granules | |
CN114591890B (en) | In-vitro model for simulating interaction of resistance blood vessel smooth muscle cells and endothelial cells and construction method thereof | |
JP7315184B2 (en) | Method for inducing differentiation from pluripotent stem cells to epidermal keratinocytes | |
CN111849884B (en) | Induction method for directional differentiation of human placental amniotic membrane stem cells into hepatocytes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |